Interestingly, ATRX mutations in NB and several other cancer types are associated with a telomerase-independent telomere maintenance mechanism known as alternative lengthening of telomeres (ALT), which is believed to be suppressed by wild-type ATRX in ALT-negative tumours [22,23]. The gene discussed is ATRX; the disease is neuroblastoma.